医学新知2025，Vol.35Issue(7)：742-749,8.DOI:10.12173/j.issn.1004-5511.202411198
中山市40岁及以上居民高血压影响因素的差异性分析
Difference analysis of hypertension risk factors of residents aged 40 and above in Zhongshan
摘要
Abstract
Objective To analyze the risk factors for hypertension and the differences across gender and age groups among residents aged 40 years and older in Zhongshan City,to provide evidence for regional hypertension prevention and control policies.Methods Data were obtained from the National Stroke High-Risk Population Screening and Intervention Project.A multistage cluster random sampling method was used to select residents who met the inclusion and exclusion criteria as study participants.Information on sociodemographic characteristics,lifestyle,and family history was collected through questionnaires.Physical and biochemical examinations were conducted to obtain body mass index,blood pressure,heart rate,fasting blood glucose,glycosylated hemoglobin,and homocysteine levels.Logistic regression analysis was used to assess the risk factors for hypertension and differences across gender and age groups.Results A total of 7,015 participants were included,3,582 people suffered from hypertension,with a hypertension prevalence rate of 51.1％.Multivariate Logistic regression analysis identified age,gender,regular alcohol consumption,family history of hypertension,history of stroke or transient ischemic attack,use of lipid-lowering medications,waist circumference,heart rate,fasting blood glucose,low-density lipoprotein cholesterol,and homocysteine levels as independent predictors of hypertension(P＜0.05).The risk factors for hypertension prevalence differed significantly between gender groups and age groups.Conclusion Multiple risk factors contribute to hypertension among residents aged 40 years and older in Zhongshan City,with notable differences across gender and age groups.关键词
高血压/危险因素/年龄/性别Key words
Hypertension/Risk factors/Age/Gender分类
医药卫生引用本文复制引用
陈洁,林海,李川..中山市40岁及以上居民高血压影响因素的差异性分析[J].医学新知,2025,35(7):742-749,8.基金项目
脑卒中高危人群筛查和干预试点项目[财政部、国家卫生健康委、国家疾控局(财社[2022]183号),财政部、国家卫生健康委、国家疾控局(财社[2022]137号)] （财社[2022]183号）
